Xconomy National

Archives

by in

Entry	Author	Date	Location
Seattle Genetics Sees Updated Side Effect Warning in Drug Label	Luke Timmerman	01/13/12	Seattle
Biogen Aims to Reduce PML Risk	Ryan McBride	12/22/10	Boston
Tysabri’s PML Count Climbs to 28, and Some Reflections From Biogen Idec’s Departing CEO	Luke Timmerman	01/06/10	Boston
Tysabri, the MS Drug Haunted by Deadly Side Effect, Doesn’t Look So Deadly Anymore	Luke Timmerman	11/19/09	Boston
Biogen Shares Drop as Tysabri PML Cases Climb to 23, Europe May Seek Drug ‘Holiday’	Luke Timmerman	10/23/09	Boston
Tysabri’s Tally of PML Cases Reaches 13	Luke Timmerman	09/17/09	Boston
Biogen Gets Int’l Rights to Acorda’s MS Drug	Roxanne Palmer	07/01/09	Boston
Biogen Reports 10th PML Case in Tysabri Patient	Roxanne Palmer	06/29/09	Boston
Biogen Idec To Show Off MS Drugs at Seattle Neurology Meeting	Luke Timmerman	04/24/09	Boston
Tysabri Patient Dies of Brain Infection, First Death Since Drug Re-Introduced	Luke Timmerman	12/19/08	Boston
Tysabri Patient Diagnosed With PML	Luke Timmerman	12/15/08	Boston
Tysabri: The Big Multiple Sclerosis Drug That Emerged From “The Hutch”	Luke Timmerman	11/04/08	Seattle
Biogen Idec, Elan’s Tysabri Linked to First U.S. Case of Brain Infection	Luke Timmerman	10/29/08	Boston
Biogen Turns Down Dying Patient’s Request For Tysabri—and Explains Why	Luke Timmerman	10/14/08	Boston
Biogen Idec, Elan Start First Cancer Trial With Tysabri	Luke Timmerman	09/05/08	Boston
FDA Doesn’t Appear Overly Alarmed by Recent Cases of Brain Disease Associated With Tysabri; Working with Biogen Idec and Elan to Update Labeling	Luke Timmerman	08/26/08	Boston
Taligen CEO Aims to Develop Drugs For Inflammatory Diseases, Build Company in Cambridge	Luke Timmerman	08/14/08	Boston
Icahn Ups Biogen Idec Stake to 6 Percent—Bought Big on Tysabri Woes	Ryan McBride	08/12/08	Boston
Biogen Idec, Elan Shares Plummet on News of Two PML Cases With Tysabri	Luke Timmerman	08/01/08	Boston
Biogen Idec, Elan Report Two New Cases of Rare Brain Infection in Tysabri Patients	Luke Timmerman	07/31/08	Boston
Biogen Idec, Elan Say More Than 31,800 Patients Taking Tysabri For MS	Luke Timmerman	07/22/08	Boston
Genzyme Reaching For a Slice From Biogen’s Breadbasket, Multiple Sclerosis Drugs	Luke Timmerman	07/17/08	Boston
Page 1 of 1